Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Gap Noted in Cardiac Risk Management in RA
Musculoskeletal Care; ePub 2017 Apr 18; Ladak, et al
There is marked underdiagnosis and undertreatment of cardiac risk in rheumatoid arthritis, according to a recent study. Several major barriers exist, including lack of time. Researchers examined 300 patient charts from 10 university-affiliated rheumatology practices, to ascertain if they had been screened, treated, and/or referred over a 3-year period. They subsequently distributed a national survey to rheumatologists to elucidate challenges in performing optimal cardiovascular risk modification. They found:
- Most patients were screened for hypertension.
- 41% were found to be hypertensive; however, the majority of these patients were neither treated nor referred to another provider for management.
- A small minority of patients was screened for diabetes and/or hyperlipidemia, and these were usually not addressed if abnormal.
- Men were referred more frequently than women.
- Consistent with these findings, the majority of rheumatologists from the national survey felt that they did not manage cardiovascular risk adequately; 79.4% cited a lack of time as a major barrier, and 82.5% felt that it should be managed by the primary care provider.
Ladak K, Hashim J, Clifford-Tashotte M, Tandon V, Matsos M, Patel A. Cardiovascular risk management in rheumatoid arthritis: A large gap to close. [Published online ahead of print April 18, 2017]. Musculoskeletal Care. doi:10.1002/msc.1196.